Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uma Suryadevara

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Asian Journal of Psychiatry|May 10, 2017
Psycho-neuro-immuno-endocrinology of schizophrenia: Back to the futureRajiv Tandon, Uma Suryadevara
Continuum (Minneapolis, Minn.)|December 9, 2021
PsychosisParunyou Julayanont, Uma Suryadevara
Asian Journal of Psychiatry|June 27, 2018
Decriminalization of Attempted Suicide across Asia- It Matters!Uma Suryadevara, Rajiv Tandon
Continuum (Minneapolis, Minn.)|December 9, 2021
Mood DisordersShae Datta, Uma Suryadevara, Josepha Cheong
Asian Journal of Psychiatry|September 14, 2014
Antipsychotic treatment of schizophrenia: an updateDawn Bruijnzeel, Uma Suryadevara, Rajiv Tandon
Journal of Clinical Psychopharmacology|October 9, 2015
Delirium Associated With Memantine Use in a Patient With Vascular DementiaDaniel Witter, Matt McCord, Uma Suryadevara
AMA Journal of Ethics|October 6, 2023
Should Antipsychotics' Risks Be Accepted by Clinicians on Behalf of Patients to Achieve Benefits of Mitigating Older Adults' Behavioral Symptoms in Short-Staffed Units?Alex Rollo, Jeena Kar, Uma Suryadevara, et al.
Asian Journal of Psychiatry|October 1, 2015
Psychiatry is a clinical neuroscience, but how do we move the field?Rajiv Tandon, Babu Rankupalli, Uma Suryadevara, et al.
Expert Opinion on Pharmacotherapy|June 27, 2015
Lurasidone in the treatment of schizophrenia: a critical evaluationDawn Bruijnzeel, Mehdi Yazdanpanah, Uma Suryadevara, et al.
Expert Opinion on Pharmacotherapy|April 27, 2017
Pharmacotherapy for the treatment of tardive dyskinesia in schizophrenia patientsDaniel P Witter, Richard C Holbert, Uma Suryadevara
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Asian Journal of Psychiatry|May 10, 2017
Psycho-neuro-immuno-endocrinology of schizophrenia: Back to the futureRajiv Tandon, Uma Suryadevara
Continuum (Minneapolis, Minn.)|December 9, 2021
PsychosisParunyou Julayanont, Uma Suryadevara
Asian Journal of Psychiatry|June 27, 2018
Decriminalization of Attempted Suicide across Asia- It Matters!Uma Suryadevara, Rajiv Tandon
Continuum (Minneapolis, Minn.)|December 9, 2021
Mood DisordersShae Datta, Uma Suryadevara, Josepha Cheong
Asian Journal of Psychiatry|September 14, 2014
Antipsychotic treatment of schizophrenia: an updateDawn Bruijnzeel, Uma Suryadevara, Rajiv Tandon
Journal of Clinical Psychopharmacology|October 9, 2015
Delirium Associated With Memantine Use in a Patient With Vascular DementiaDaniel Witter, Matt McCord, Uma Suryadevara
AMA Journal of Ethics|October 6, 2023
Should Antipsychotics' Risks Be Accepted by Clinicians on Behalf of Patients to Achieve Benefits of Mitigating Older Adults' Behavioral Symptoms in Short-Staffed Units?Alex Rollo, Jeena Kar, Uma Suryadevara, et al.
Asian Journal of Psychiatry|October 1, 2015
Psychiatry is a clinical neuroscience, but how do we move the field?Rajiv Tandon, Babu Rankupalli, Uma Suryadevara, et al.
Expert Opinion on Pharmacotherapy|June 27, 2015
Lurasidone in the treatment of schizophrenia: a critical evaluationDawn Bruijnzeel, Mehdi Yazdanpanah, Uma Suryadevara, et al.
Expert Opinion on Pharmacotherapy|April 27, 2017
Pharmacotherapy for the treatment of tardive dyskinesia in schizophrenia patientsDaniel P Witter, Richard C Holbert, Uma Suryadevara
Pageof 2